Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

Holding(s) in Company

April 12, 2024
RNS Number : 5019K Renalytix PLC 12 April 2024   S tandard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer of existing shares: Renalytix PLC 1b. Please indicate if the issuer is a non- UK issuer    (please mark with an "X"

Rule 2.9 Announcement

April 12, 2024
RNS Number : 3586K Renalytix PLC 12 April 2024   Renalytix plc ("Renalytix" or the "Company")   Rule 2.9 Announcement   LONDON and SALT LAKE CITY -   12 April 2024   -   Renalytix plc   (NASDAQ: RNLX) (LSE: RENX) , in   accordance with Rule 2.9 of the City Code on Takeovers and Mergers and further

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

April 10, 2024
RNS Number : 0147K Stifel Nicolaus Europe Limited 10 April 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name

Issue of Shares

April 10, 2024
RNS Number : 0298K Renalytix PLC 10 April 2024   Renalytix plc ("Renalytix" or the "Company")   Issue of Shares   LONDON and SALT LAKE CITY -   10 April 2024 -   Renalytix plc   (NASDAQ: RNLX) (LSE: RENX) , announces the repayment of $1.06 million of principal and interest amount due under the

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

April 9, 2024
RNS Number : 8412J Stifel Nicolaus Europe Limited 09 April 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

April 8, 2024
RNS Number : 6587J Stifel Nicolaus Europe Limited 08 April 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name

Financing with Expected Size of up to $4 Million

April 8, 2024
RNS Number : 6496J Renalytix PLC 08 April 2024   NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES , CANADA , AUSTRALIA , JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR IN OR INTO ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

April 5, 2024
RNS Number : 4934J Stifel Nicolaus Europe Limited 05 April 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name

Change of Registered Address

April 5, 2024
RNS Number : 5295J Renalytix PLC 05 April 2024     Renalytix plc ("Renalytix" or the "Company")   Change of Registered Address   LONDON and SALT LAKE CITY , April 5, 2024 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on
Displaying 1 - 10 of 483